D-0727-2018 Class II Terminated
FDA drug recall D-0727-2018 was initiated by Dr. Reddy's Laboratories, Inc. on Apr 23, 2018 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets. The recall status is terminated (terminated Dec 14, 2020). Affected quantity: 8160 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- May 16, 2018
- Initiation Date
- Apr 23, 2018
- Termination Date
- Dec 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8160 bottles
Product Description
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01
Reason for Recall
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.
Distribution Pattern
Nationwide
Code Information
Batch # C706254, 08/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0727-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026